Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Mucositis D052016 7 associated lipids
Bronchiectasis D001987 7 associated lipids
Agranulocytosis D000380 7 associated lipids
Pneumococcal Infections D011008 7 associated lipids
Rheumatic Diseases D012216 7 associated lipids
Pelvic Pain D017699 7 associated lipids
Coronary Thrombosis D003328 7 associated lipids
Ear Diseases D004427 7 associated lipids
Postoperative Hemorrhage D019106 7 associated lipids
Rhinitis, Allergic, Seasonal D006255 7 associated lipids
Klebsiella Infections D007710 7 associated lipids
Corneal Neovascularization D016510 8 associated lipids
Lupus Nephritis D008181 8 associated lipids
Aggressive Periodontitis D010520 8 associated lipids
Tangier Disease D013631 8 associated lipids
Tumor Virus Infections D014412 8 associated lipids
Constriction, Pathologic D003251 8 associated lipids
Thalassemia D013789 8 associated lipids
Arteriosclerosis Obliterans D001162 8 associated lipids
Carcinoma, Embryonal D018236 8 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Leff AR Neurohumoral regulation of airway contractile responses. 1988 Chest pmid:2897271
Junier MP et al. Inhibitory effect of platelet-activating factor (PAF) on luteinizing hormone-releasing hormone and somatostatin release from rat median eminence in vitro correlated with the characterization of specific PAF receptor sites in rat hypothalamus. 1988 Endocrinology pmid:2898362
Guinot P et al. Treatment of adult systemic mastocytosis with a PAF-acether antagonist BN52063. 1988 Lancet pmid:2898694
Michel L et al. Inhibitory effect of oral cetirizine on in vivo antigen-induced histamine and PAF-acether release and eosinophil recruitment in human skin. 1988 J. Allergy Clin. Immunol. pmid:2899102
Michel L et al. Release of PAF-acether and precursors during allergic cutaneous reactions. 1988 Lancet pmid:2899817
Lerner R et al. Platelet activating factor and leukotriene B4 induce hyperpolarization of human endothelial cells but depolarization of neutrophils. 1988 Biochem. Biophys. Res. Commun. pmid:2838025
Mangold HK Synthesis of biologically active ether lipids. 1988 Prog Biochem Pharmacol pmid:3136454
Anderson GP et al. Increased airways responsiveness to histamine induced by platelet activating factor in the guinea-pig: possible role of lipoxygenase metabolites. 1988 Agents Actions pmid:3136622
Fernandez-Gallardo S et al. Role of paf-acether in the mediation of pathophysiological responses to aggregated immunoglobulins. Studies with the platelet-activating factor receptor antagonist BN 52021. 1988 Int. J. Immunopharmacol. pmid:3139574
Slapke J et al. [Test hierarchy for the development of new drug action principles with the action site in phospholipid metabolism for bronchial asthma and pulmonary hypertension]. 1988 Prax Klin Pneumol pmid:3140230
Lefort J et al. Pharmacological profile of 48740 R.P., a PAF-acether antagonist. 1988 Eur. J. Pharmacol. pmid:2843382
Winkler JD et al. Leukotriene B4-induced homologous desensitization of calcium mobilization and phosphoinositide metabolism in U-937 cells. 1988 J. Pharmacol. Exp. Ther. pmid:2839662
Sun XM and Hsueh W Bowel necrosis induced by tumor necrosis factor in rats is mediated by platelet-activating factor. 1988 J. Clin. Invest. pmid:3366898
Calignano A et al. Isolation and identification of platelet-activating factor in UV-irradiated guinea pig skin. 1988 J Pharmacol Methods pmid:3367652
Nolte D [Bronchial hyperreactivity: pingpong between cells, nerves and mediators]. 1988 Med. Klin. (Munich) pmid:3367876
Bratton DL et al. Effects of platelet activating factor and related lipids on phase transition of dipalmitoylphosphatidylcholine. 1988 Biochim. Biophys. Acta pmid:3370214
Wang J et al. The effects of endotoxin on platelet-activating factor synthesis in cultured rat glomerular mesangial cells. 1988 Biochim. Biophys. Acta pmid:3370222
Grue-Sørensen G et al. Derivatives of 2-methylenepropane-1,3-diol as new antagonists of platelet activating factor. 1988 J. Med. Chem. pmid:3373485
Pirotzky E et al. Protection of platelet-activating factor-induced acute renal failure by BN 52021. 1988 Br J Exp Pathol pmid:3377967
O'Flaherty JT et al. Mechanism involved in the mobilization of neutrophil calcium by 5-hydroxyeicosatetraenoate. 1988 J. Immunol. pmid:2836511
Spinks NR and O'Neill C Antagonists of embryo-derived platelet-activating factor prevent implantation of mouse embryos. 1988 J. Reprod. Fertil. pmid:2460623
Dorsch W et al. Anti-asthmatic effects of onions. Alk(en)ylsulfinothioic acid alk(en)yl-esters inhibit histamine release, leukotriene and thromboxane biosynthesis in vitro and counteract PAF and allergen-induced bronchial obstruction in vivo. 1988 Biochem. Pharmacol. pmid:2462422
Wallace JL and MacNaughton WK Gastrointestinal damage induced by platelet-activating factor: role of leukotrienes. 1988 Eur. J. Pharmacol. pmid:2843390
Kok PT et al. Arachidonic acid can induce leukotriene C4 formation by purified human eosinophils in the absence of other stimuli. 1988 Biochem. Biophys. Res. Commun. pmid:3132917
Groscurth P et al. Effects of platelet activating factor (PAF) on human citrated whole blood. 1988 Eur. J. Haematol. pmid:3402585
Rylander R et al. Modulation of pulmonary inflammation after endotoxin inhalation with a platelet-activating factor antagonist (48740 RP). 1988 Int. Arch. Allergy Appl. Immunol. pmid:3403044
Satoh K et al. [Endothelial injury as an initiating factor: vascular endothelial cell injury and biosynthesis of PAF]. 1988 Nippon Rinsho pmid:3404682
Nogami M et al. [Effects of a PAF antagonist CV-3988 on the acute gastric erosions of rats by water-immersion stress]. 1988 Nihon Shokakibyo Gakkai Zasshi pmid:3404759
Biologically active ether lipids. 1988 Prog Biochem Pharmacol pmid:3405995
Taira M et al. Lack of involvement of leukotriene and platelet activating factor in passive cutaneous anaphylaxis in rats. 1988 Agents Actions pmid:3407549
Roberts NM et al. Effect of a PAF antagonist, BN52063, on antigen-induced, acute, and late-onset cutaneous responses in atopic subjects. 1988 J. Allergy Clin. Immunol. pmid:3403863
Mollinedo F et al. Intracellular localization of platelet-activating factor synthesis in human neutrophils. 1988 Biochem. Biophys. Res. Commun. pmid:3408495
Koenderman L et al. An improved method for the isolation of eosinophilic granulocytes from peripheral blood of normal individuals. 1988 J. Leukoc. Biol. pmid:3404069
Anderson GP and Fennessy MR Lipoxygenase metabolites as mediators of platelet activating factor-induced increased airways responsiveness to histamine in the guinea-pig. 1988 Agents Actions Suppl. pmid:3140616
Coyle AJ et al. The effect of the selective PAF antagonist BN 52021 on PAF- and antigen-induced bronchial hyper-reactivity and eosinophil accumulation. 1988 Eur. J. Pharmacol. pmid:3383997
Tokumura A et al. Study of platelet activating factor and its antagonists on rat colon strip with a new method avoiding tachyphylaxis. 1988 Eur. J. Pharmacol. pmid:3384001
Bass DA et al. Selective priming of rate and duration of the respiratory burst of neutrophils by 1,2-diacyl and 1-O-alkyl-2-acyl diglycerides. Possible relation to effects on protein kinase C. 1988 J. Biol. Chem. pmid:3198643
Lewis MS et al. Hydrogen peroxide stimulates the synthesis of platelet-activating factor by endothelium and induces endothelial cell-dependent neutrophil adhesion. 1988 J. Clin. Invest. pmid:3198764
Misawa M and Takata T Effects of platelet-activating factor on rat airways. 1988 Jpn. J. Pharmacol. pmid:3199608
Kato T et al. Augmentation of DNA synthesis in guinea pig bone marrow cells by platelet-activating factor (PAF). 1988 Biochem. Biophys. Res. Commun. pmid:3202869
Keery RJ and Lumley P AH6809, a prostaglandin DP-receptor blocking drug on human platelets. 1988 Br. J. Pharmacol. pmid:2460179
Roberts NM et al. Effect of a PAF antagonist, BN52063, on PAF-induced bronchoconstriction in normal subjects. 1988 Br J Clin Pharmacol pmid:3203062
Freitas JC et al. Inhibition of platelet aggregation by manoalide: preliminary results. 1988 Braz. J. Med. Biol. Res. pmid:3203166
Jancar S et al. Immune complex induced pancreatitis: effect of BN 52021, a selective antagonist of platelet-activating factor. 1988 Prostaglandins pmid:2969600
Collier M et al. Biochemical and pharmacological characterization of human embryo-derived platelet activating factor. 1988 Hum. Reprod. pmid:3204154
Tkhostov EB et al. [Calcium metabolism in arterial hypertension. I. Myocardial hypertrophy and hormone-dependent increase in Ca2+ levels in the thrombocytes of patients with arterial hypertension]. 1988 Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR pmid:2969736
Leprevost C et al. Inhibition of eosinophil chemotaxis by a new antiallergic compound (cetirizine). 1988 Int. Arch. Allergy Appl. Immunol. pmid:2971624
Ohmori K et al. Antiinflammatory and antiallergic effects of a novel metabolite of Nocardiopsis sp. as a potent protein kinase C inhibitor from microbial origin. 1988 Arzneimittelforschung pmid:2972291
Masugi F et al. Platelet-activating factor and anti-platelet-aggregating factor in acute reduction of blood pressure following percutaneous transluminal renal angioplasty in patients with renovascular hypertension. 1988 J Hum Hypertens pmid:2977405
Moriyama T et al. Elevation of cytosolic free Ca2+ is directly evoked by thromboxane A2 in human platelets during activation with collagen. 1988 J. Biochem. pmid:3170519
Lagente V et al. PAF-acether and endotoxin display similar effects on rat mesenteric microvessels: inhibition by specific antagonists. 1988 J. Pharmacol. Exp. Ther. pmid:3171975
Danko G et al. Effect of the PAF antagonists, CV-3988 and L-652,731 on the pulmonary and hematological responses to guinea pig anaphylaxis. 1988 Pharmacol Res Commun pmid:3174804
Bussolino F et al. Platelet activating factor induces dopamine release in PC-12 cell line. 1988 Am. J. Physiol. pmid:3177629
Hill CE et al. Location of platelet activating factor binding in rat liver. 1988 Biochem. J. pmid:3178735
Crouch MF and Lapetina EG Spacial isolation of protein kinase C activation in thrombin stimulated human platelets. 1988 Biochem. Biophys. Res. Commun. pmid:3178827
Andersson M and Pipkorn U The effect of platelet activating factor on nasal hypersensitivity. 1988 Eur. J. Clin. Pharmacol. pmid:3181276
Ferguson MK et al. Lymphatic smooth muscle responses to leukotrienes, histamine and platelet activating factor. 1988 J. Surg. Res. pmid:3339877
Kelefiotis D et al. Study of digoxin as inhibitor of the in vivo effects of acetyl glyceryl ether phosphorylcholine (AGEPC) in mice. 1988 Life Sci. pmid:3339951
Soybel DI et al. Effects of platelet-activating factor on canine gastric mucosal blood flow and permeability to luminal acid. 1988 Am. J. Surg. pmid:3341532
Kumar R et al. Occurrence of platelet-activating factor in rabbit spermatozoa. 1988 Arch. Biochem. Biophys. pmid:3341753
Huo YN et al. A preferential inhibition by Zn2+ on platelet activating factor- and thrombin-induced serotonin secretion from washed rabbit platelets. 1988 Arch. Biochem. Biophys. pmid:3341767
Whatley RE et al. The regulation of synthesis of platelet-activating factor by endothelial cells. 1988 Chest pmid:3342689
Ukena D et al. Radioligand binding of antagonists of platelet-activating factor to intact human platelets. 1988 FEBS Lett. pmid:3342883
O'Donnell SR and Barnett CJ pA2 values for antagonists of platelet activating factor on aggregation of rabbit platelets. 1988 Br. J. Pharmacol. pmid:3293683
Giovannini L et al. N-acetyl-beta-glucosaminidase (NAG) and alpha-glycosidase released by PAF in isolated perfused rat kidney. 1988 Int J Tissue React pmid:3294206
Kramer RM et al. Hydrolysis of 1-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine, a common precursor of platelet-activating factor and eicosanoids, by human platelet phospholipase A2. 1988 Biochim. Biophys. Acta pmid:3355850
McGowan HM et al. Increased levels of platelet-activating factor (1-O-alkyl-2-acetylglycerophosphocholine) in blood after reversal of renal clip hypertension in the rat. 1988 Clin. Sci. pmid:3356112
Quinn MT et al. Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis. 1988 Proc. Natl. Acad. Sci. U.S.A. pmid:3357891
Tatsumi N et al. Neutrophil chemiluminescence induced by platelet activating factor and suppressed by C-reactive protein. 1988 Clin. Chim. Acta pmid:3359655
Rola-Pleszczynski M et al. Immune regulation by platelet-activating factor. I. Induction of suppressor cell activity in human monocytes and CD8+ T cells and of helper cell activity in CD4+ T cells. 1988 J. Immunol. pmid:2834440
Hsueh W et al. Sequential release of leukotrienes and norepinephrine in rat bowel after platelet-activating factor. A mechanistic study of platelet-activating factor-induced bowel necrosis. 1988 Gastroenterology pmid:3360262
Worthen GS et al. The priming of neutrophils by lipopolysaccharide for production of intracellular platelet-activating factor. Potential role in mediation of enhanced superoxide secretion. 1988 J. Immunol. pmid:2834441
Hasegawa T and Nakajima S [Recent topics on platelet-activating-factor (PAF)]. 1988 Nippon Ika Daigaku Zasshi pmid:3360909
Touvay C et al. Role of platelet-activating factor (PAF) in the bronchopulmonary alterations and beta-adrenoceptor function induced by endotoxin. 1988 Biochem. Biophys. Res. Commun. pmid:2835036
17th annual UCLA symposium. Abstracts: Cell activation and signal initiation: receptor and phospholipase control of inositol phosphate, PAF and eicosanoid production. 1988 J. Cell. Biochem. Suppl. pmid:2835556
Paulson SK and Nicholson NS A radioreceptor binding assay for measurement of platelet-activating factor synthesis by human neutrophils. 1988 J. Immunol. Methods pmid:2837517
Errasfa M et al. Inhibition of phospholipase A2 activity of guinea-pig alveolar macrophages by lipocortin-like proteins purified from mice lung. 1988 Biochem. Biophys. Res. Commun. pmid:2968795
Shkhvatsabaia IK et al. [Receptor-dependent regulation of the concentration of Ca2+ in the cytoplasm of thrombocytes in hypertensive patients]. 1988 Kardiologiia pmid:2842537
Tahraoui L et al. High affinity specific binding sites for tritiated platelet-activating factor in canine platelet membranes: counterparts of platelet-activating factor receptors mediating platelet aggregation. 1988 Mol. Pharmacol. pmid:2842653
Garcia JG et al. Effect of platelet activating factor on leukocyte-endothelial cell interactions. 1988 Thromb. Res. pmid:2842887
Eliakim R et al. Role of platelet-activating factor in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine and prednisolone. 1988 Gastroenterology pmid:2901995
Ng DS and Wong K Specific binding of platelet-activating factor (PAF) by human peripheral blood mononuclear leukocytes. 1988 Biochem. Biophys. Res. Commun. pmid:2843182
Breviario F et al. IL-1-induced adhesion of polymorphonuclear leukocytes to cultured human endothelial cells. Role of platelet-activating factor. 1988 J. Immunol. pmid:3263425
Page CP The role of platelet-activating factor in asthma. 1988 J. Allergy Clin. Immunol. pmid:3276759
Browne PC et al. Kinetics of the formation of thrombin-thrombospondin complexes: involvement of a 77-kDa intermediate. 1988 Arch. Biochem. Biophys. pmid:2844122
Barnes PJ Platelet-activating factor and asthma. 1988 J. Allergy Clin. Immunol. pmid:3276760
Royall JA and Levin DL Adult respiratory distress syndrome in pediatric patients. I. Clinical aspects, pathophysiology, pathology, and mechanisms of lung injury. 1988 J. Pediatr. pmid:3276861
Vanhoutte PM Platelets, endothelium and blood vessel wall. 1988 Experientia pmid:3278917
Lellouch-Tubiana A et al. Eosinophil recruitment into guinea pig lungs after PAF-acether and allergen administration. Modulation by prostacyclin, platelet depletion, and selective antagonists. 1988 Am. Rev. Respir. Dis. pmid:3281530
Chung KF and Barnes PJ PAF antagonists. Their potential therapeutic role in asthma. 1988 Drugs pmid:3281823
Doni MG et al. Forskolin and prostacyclin inhibit fluoride induced platelet activation and protein kinase C dependent responses. 1988 Biochem. Biophys. Res. Commun. pmid:2847730
Ghigo D et al. Role of Na+/H+ exchange in thrombin-induced platelet-activating factor production by human endothelial cells. 1988 J. Biol. Chem. pmid:2848827
Aratani H et al. Effect of etizolam (Depas) on production of superoxide anion by platelet-activating factor and N-formyl-methionyl-leucyl-phenylalanine-stimulated guinea pig polymorphonuclear leukocytes. 1988 Jpn. J. Pharmacol. pmid:2848961
Robertson DN et al. The effect of platelet-activating factor on histamine and muscarinic receptor function in guinea pig airways. 1988 Am. Rev. Respir. Dis. pmid:2849329
Stewart AG and Dusting GJ Characterization of receptors for platelet-activating factor on platelets, polymorphonuclear leukocytes and macrophages. 1988 Br. J. Pharmacol. pmid:2850058
Korth R et al. Comparison of three paf-acether receptor antagonist ginkgolides. 1988 Eur. J. Pharmacol. pmid:2850196
Bussolino F [Production of PAF (1-0-alkyl-2-acetyl-sn-glycero-3-phosphocholine) in the chick retina during embryogenesis]. 1988 Ann. Ist. Super. Sanita pmid:3218801
Dillon PK et al. Effect of platelet-activating factor on leukocyte adhesion to microvascular endothelium. Time course and dose-response relationships. 1988 Inflammation pmid:3220518
Lohmann HF et al. Idiopathic thrombocytopenia treated with Paf-acether antagonist WEB 2086. 1988 Lancet pmid:2903365
White HL and Faison LD Inhibition of lyso-PAF: acetyl-CoA acetyltransferase by salicylates and other compounds. 1988 Prostaglandins pmid:2903520